Structures by: Ramachandran R.
Total: 17
C40H34ClN3OP2RuS
C40H34ClN3OP2RuS
Dalton transactions (Cambridge, England : 2003) (2014) 43, 21 7889-7902
a=14.3388(8)Å b=16.6137(6)Å c=15.0818(8)Å
α=90° β=96.268(4)° γ=90°
C39H32ClN3OP2RuS,0.5(C2H8O2)
C39H32ClN3OP2RuS,0.5(C2H8O2)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 21 7889-7902
a=14.3822(5)Å b=16.6752(6)Å c=15.1543(4)Å
α=90.00° β=96.312(3)° γ=90.00°
C45H36AsClN3OPRuS
C45H36AsClN3OPRuS
Dalton transactions (Cambridge, England : 2003) (2014) 43, 21 7889-7902
a=10.2991(8)Å b=13.1254(11)Å c=15.2952(13)Å
α=97.686(7)° β=94.380(7)° γ=96.521(7)°
C41H36ClN3OP2RuS
C41H36ClN3OP2RuS
RSC Adv. (2015)
a=14.3401(5)Å b=16.5933(5)Å c=15.1214(5)Å
α=90.00° β=96.3390(10)° γ=90.00°
C44H42N6P2RuS2
C44H42N6P2RuS2
RSC Adv. (2015)
a=11.080(2)Å b=22.178(4)Å c=16.849(3)Å
α=90.00° β=90.00° γ=90.00°
C59H52N3OP3RuS
C59H52N3OP3RuS
RSC Adv. (2015)
a=9.4861(4)Å b=13.3046(5)Å c=21.9391(9)Å
α=86.469(3)° β=79.675(3)° γ=71.360(3)°
R-2,c-6-Bis(3-fluorophenyl)t-3,t-5-dimethylpiperidin-4-one
C19H17F2NO
Acta Crystallographica Section E (2007) 63, 12 o4559-o4559
a=22.2891(4)Å b=7.05160(10)Å c=23.4565(4)Å
α=90.00° β=117.711(2)° γ=90.00°
1-Bromoacetyl-2,6-bis(4-methoxyphenyl)-3,5-dimethylpiperidin-4-one
C23H26BrNO4
Acta Crystallographica Section E (2008) 64, 10 o2009-o2010
a=12.9487(9)Å b=25.2882(18)Å c=8.9701(6)Å
α=90.00° β=132.9300(10)° γ=90.00°
1-chloroacetyl-3-ethyl-2,6-diphenylpiperidin-4-one oxime
C21H23ClN2O2
Acta Crystallographica Section C (2010) 66, 6 o274-o278
a=34.176(3)Å b=9.1227(9)Å c=12.1235(11)Å
α=90.00° β=91.962(8)° γ=90.00°
1-chloroacetyl-3-ethyl-2,6-diphenylpiperidin-4-one oxime
C21H23ClN2O2
Acta Crystallographica Section C (2010) 66, 6 o274-o278
a=33.849(3)Å b=9.0250(10)Å c=11.9800(10)Å
α=90.00° β=92.510(10)° γ=90.00°
1-chloroacetyl-2,6-diphenyl-3-(propan-2-yl)piperidin-4-one oxime
C22H25ClN2O2
Acta Crystallographica Section C (2010) 66, 6 o274-o278
a=9.4690(10)Å b=16.658(2)Å c=12.653(2)Å
α=90.00° β=90.290(10)° γ=90.00°
1-Chloroacetyl-2,6-bis(2-chlorophenyl)-3,5-dimethylpiperidin-4-one
C21H20Cl3NO2
Acta Crystallographica Section E (2010) 66, 9 o2284
a=11.6295(4)Å b=9.6955(3)Å c=17.4743(5)Å
α=90.00° β=90.4810(10)° γ=90.00°
2-(2,4-Diphenyl-3-azabicyclo[3.3.1]nonan-9-ylidenehydrazono)- 1,3-thiazolidin-4-one
C23H24N4OS
Acta Crystallographica Section E (2009) 65, 3 o584
a=8.3183(3)Å b=10.8435(4)Å c=22.7417(8)Å
α=90.00° β=92.483(2)° γ=90.00°
Ethyl 4-hydroxy-1-(2-morpholinopropanoyl)-2,6-diphenyl- 1,2,5,6-tetrahydropyridin-3-carboxylate
C27H32N2O5
Acta Crystallographica Section E (2009) 65, 12 o3232-o3233
a=8.2251(2)Å b=10.6219(4)Å c=28.7046(10)Å
α=90.00° β=92.375(2)° γ=90.00°
2,6-Bis(3-fluorophenyl)-3-isopropylpiperidin-4-one
C20H21F2NO
Acta Crystallographica Section E (2010) 66, 7 o1860
a=8.8217(3)Å b=12.7612(4)Å c=30.8613(9)Å
α=90.00° β=91.892(2)° γ=90.00°
Ethyl 4-[2-(3,5-dimethyl-4-oxo-2,6-diphenylpiperidin-1- yl)-2-oxoethyl]piperazine-1-carboxylate
C28H35N3O4
Acta Crystallographica Section E (2011) 67, 3 o541
a=10.9073(3)Å b=19.1940(6)Å c=12.2246(3)Å
α=90.00° β=91.809(2)° γ=90.00°
(<i>E</i>)-3-(4-Methylphenyl)-1-(1,3-thiazol-2-yl)prop-2-en-1-one
C13H11NOS
Acta Crystallographica Section E (2012) 68, 6 o1875
a=13.9486(9)Å b=11.1773(8)Å c=7.4579(5)Å
α=90.00° β=102.061(4)° γ=90.00°